Pathologic Stage III Cutaneous Melanoma AJCC v8
generalStage IIIB includes: (T0, N1b, N1c, M0); (T1a/b-T2a, N1b/c or N2b, M0); (T2b/T3a, N1a-N2b, M0). T0: No evidence of primary tumor (e.g., unknown primary or completely regressed melanoma). Thickness: Not applicable. Ulceration status: Not applicable. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or
22
Centers
24
Active Trials
$4.2B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Melanoma Stage IIIC | 19 |
Top Centers for Pathologic Stage III Cutaneous Melanoma AJCC v8(22)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →